Zacks.com on MSN1d
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?We expect BioNTech SE BNTX to surpass expectations when it reports first-quarter 2024 results on May 6, before the opening ...
GlaxoSmithKline filed a four-count civil action for patent infringement in the United States District Court for the District ...
GlaxoSmithKline filed a federal lawsuit seeking to recoup a share of the tens of billions of dollars in revenue Pfizer and ...
Shortly after winning a stay on a COVID-19 vaccine patent lawsuit brought by Moderna, Pfizer and its German partner BioNTech ...
With its lawsuit filed against Pfizer and BioNTech, the British multinational biopharma has joined the high-profile patent ...
We previously reported on the litigation brought by ModernaTX, Inc. and Moderna US, Inc. (collectively, “Moderna”) against BioNTech SE, BioNTech Manufacturing GmbH, BioNTech US Inc. (collectively, ...
GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents ...
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) ...
GSK initiates legal proceedings against Pfizer and BioNTech over alleged COVID-19 vaccine patent infringement, intensifying ...
8don MSN
Moderna challenges Pfizer and BioNTech in a London patent trial over mRNA vaccine patents. The outcome may reshape the ...
Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines ...
GlaxoSmithKline (GLAX.NS) sued Pfizer (PFE.N) and BioNTech (22UAy.DE) in Delaware federal court on Thursday, accusing them of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results